Zhejiang Jiuzhou Pharmaceutical Co., Ltd

SHSE:603456 Stok Raporu

Piyasa değeri: CN¥13.9b

Zhejiang Jiuzhou Pharmaceutical Temettü

Temettü kriter kontrolleri 3/6

Zhejiang Jiuzhou Pharmaceutical is a dividend paying company with a current yield of 3.23% that is well covered by earnings.

Anahtar bilgiler

3.2%

Temettü verimi

0.009%

Geri Alım Getirisi

Toplam Hissedar Getirisi3.2%
Gelecekteki Temettü Verimi4.6%
Temettü Büyümesi19.0%
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettüCN¥0.500
Ödeme oranı65%

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) Shares Leap 25% Yet They're Still Not Telling The Full Story

Oct 01
Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) Shares Leap 25% Yet They're Still Not Telling The Full Story

Zhejiang Jiuzhou Pharmaceutical (SHSE:603456) Seems To Use Debt Quite Sensibly

Sep 25
Zhejiang Jiuzhou Pharmaceutical (SHSE:603456) Seems To Use Debt Quite Sensibly

Here's Why Zhejiang Jiuzhou Pharmaceutical (SHSE:603456) Can Manage Its Debt Responsibly

Jun 13
Here's Why Zhejiang Jiuzhou Pharmaceutical (SHSE:603456) Can Manage Its Debt Responsibly

Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) Business And Shares Still Trailing The Market

May 24
Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) Business And Shares Still Trailing The Market

Zhejiang Jiuzhou Pharmaceutical's (SHSE:603456) Solid Earnings May Rest On Weak Foundations

May 01
Zhejiang Jiuzhou Pharmaceutical's (SHSE:603456) Solid Earnings May Rest On Weak Foundations

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Just Missed Revenue By 17%: Here's What Analysts Think Will Happen Next

Apr 11
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Just Missed Revenue By 17%: Here's What Analysts Think Will Happen Next

Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:603456) Shares Could Be 32% Above Their Intrinsic Value Estimate

Feb 28
Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:603456) Shares Could Be 32% Above Their Intrinsic Value Estimate

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: 603456 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Büyüyen Temettü: 603456's dividend payments have increased, but the company has only paid a dividend for 9 years.


Piyasaya Karşı Temettü Getirisi

Zhejiang Jiuzhou Pharmaceutical Piyasaya Karşı Temettü Getirisi
603456 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (603456)3.2%
Pazarın Alt %25'i (CN)0.6%
Pazarın En İyi %25'i (CN)2.2%
Sektör Ortalaması (Pharmaceuticals)1.7%
Analist tahmini (603456) (3 yıla kadar)4.6%

Önemli Temettü: 603456's dividend (3.23%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).

Yüksek Temettü: 603456's dividend (3.23%) is in the top 25% of dividend payers in the CN market (2.22%)


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: With its reasonable payout ratio (64.6%), 603456's dividend payments are covered by earnings.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: 603456 is paying a dividend but the company has no free cash flows.


Güçlü temettü ödeyen şirketleri keşfedin